Giulia Venturini1, Hanna Koskiniemi-Kuendig1, Shyana Harper2, Eliot L Berson2, Carlo Rivolta1. 1. Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland. 2. The Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
Abstract
PURPOSE: Retinitis pigmentosa is a Mendelian disease with a very elevated genetic heterogeneity. Most mutations are responsible for less than 1% of cases, making molecular diagnosis a multigene screening procedure. In this study, we assessed whether direct testing of specific alleles could be a valuable screening approach in cases characterized by prevalent founder mutations. METHODS: We screened 275 North American patients with recessive/isolate retinitis pigmentosa for two mutations: an Alu insertion in the MAK gene and the p.Lys42Glu missense in the DHDDS gene. All patients were unrelated; 35 reported Jewish ancestry and the remainder reported mixed ethnicity. RESULTS: We identified the MAK and DHDDS mutations homozygously in only 2.1% and 0.8%, respectively, of patients of mixed ethnicity, but in 25.7% and 8.6%, respectively, of cases reporting Jewish ancestry. Haplotype analyses revealed that inheritance of the MAK mutation was attributable to a founder effect. CONCLUSION: In contrast to most mutations associated with retinitis pigmentosa-which are, in general, extremely rare-the two alleles investigated here cause disease in approximately one-third of North American patients reporting Jewish ancestry. Therefore, their screening constitutes an alternative procedure to large-scale tests for patients belonging to this ethnic group, especially in time-sensitive situations.
PURPOSE: Retinitis pigmentosa is a Mendelian disease with a very elevated genetic heterogeneity. Most mutations are responsible for less than 1% of cases, making molecular diagnosis a multigene screening procedure. In this study, we assessed whether direct testing of specific alleles could be a valuable screening approach in cases characterized by prevalent founder mutations. METHODS: We screened 275 North American patients with recessive/isolate retinitis pigmentosa for two mutations: an Alu insertion in the MAK gene and the p.Lys42Glu missense in the DHDDS gene. All patients were unrelated; 35 reported Jewish ancestry and the remainder reported mixed ethnicity. RESULTS: We identified the MAK and DHDDS mutations homozygously in only 2.1% and 0.8%, respectively, of patients of mixed ethnicity, but in 25.7% and 8.6%, respectively, of cases reporting Jewish ancestry. Haplotype analyses revealed that inheritance of the MAK mutation was attributable to a founder effect. CONCLUSION: In contrast to most mutations associated with retinitis pigmentosa-which are, in general, extremely rare-the two alleles investigated here cause disease in approximately one-third of North American patients reporting Jewish ancestry. Therefore, their screening constitutes an alternative procedure to large-scale tests for patients belonging to this ethnic group, especially in time-sensitive situations.
Authors: Rıza Köksal Ozgül; Anna M Siemiatkowska; Didem Yücel; Connie A Myers; Rob W J Collin; Marijke N Zonneveld; Avigail Beryozkin; Eyal Banin; Carel B Hoyng; L Ingeborgh van den Born; Ron Bose; Wei Shen; Dror Sharon; Frans P M Cremers; B Jeroen Klevering; Anneke I den Hollander; Joseph C Corbo Journal: Am J Hum Genet Date: 2011-08-12 Impact factor: 11.025
Authors: Waldo Herrera; Tomas S Aleman; Artur V Cideciyan; Alejandro J Roman; Eyal Banin; Tamar Ben-Yosef; Leigh M Gardner; Alexander Sumaroka; Elizabeth A M Windsor; Sharon B Schwartz; Edwin M Stone; Xue-Zhong Liu; William J Kimberling; Samuel G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 2008-02-15 Impact factor: 4.799
Authors: Doron M Behar; Saharon Rosset; Jason Blue-Smith; Oleg Balanovsky; Shay Tzur; David Comas; R John Mitchell; Lluis Quintana-Murci; Chris Tyler-Smith; R Spencer Wells Journal: PLoS Genet Date: 2007-06 Impact factor: 5.917
Authors: Rodrigo Matsui; Artur V Cideciyan; Sharon B Schwartz; Alexander Sumaroka; Alejandro J Roman; Malgorzata Swider; Wei Chieh Huang; Rebecca Sheplock; Samuel G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 2015-09 Impact factor: 4.799
Authors: Pooja Biswas; Jacque L Duncan; Bruno Maranhao; Igor Kozak; Kari Branham; Luis Gabriel; Jonathan H Lin; Giulio Barteselli; Mili Navani; John Suk; Michelle Parke; Catherine Schlechter; Richard G Weleber; John R Heckenlively; Gislin Dagnelie; Pauline Lee; S Amer Riazuddin; Radha Ayyagari Journal: Physiol Genomics Date: 2017-01-27 Impact factor: 3.107